Literature DB >> 18475440

Endotoxin and cytokines in patients with gastrointestinal tract perforation.

S Endo1, K Inada, Y Inoue, T Otsu, T Kasai, Y Kuwata, S Hoshi, M Yoshida.   

Abstract

Plasma levels of endotoxin and various cytokines were assessed in 70 patients with gastrointestinal tract perforation. Sepsis developed in 29 of them, and eight of these (27.6%) had on admission endotoxin levels higher than 9.8 pg ml(-1). The clinical outcome correlated with the level of tumour necrosis factor alpha (TNFalpha), rather than with the endotoxin level. The high interleukin 6 (IL-6) level was shown in septic patients and no correlation was observed between the IL-6 level and the clinical outcome. Plasma TNFalpha levels tended to change independently from endotoxin levels, suggesting that TNFalpha may have been locally produced in inflammatory lesions.

Entities:  

Year:  1992        PMID: 18475440      PMCID: PMC2365315          DOI: 10.1155/S0962935192000097

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  7 in total

1.  Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo.

Authors:  M R Shalaby; A Waage; L Aarden; T Espevik
Journal:  Clin Immunol Immunopathol       Date:  1989-12

2.  Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock.

Authors:  T Mózes; S Ben-Efraim; C J Tak; J P Heiligers; P R Saxena; I L Bonta
Journal:  Immunol Lett       Date:  1991-02       Impact factor: 3.685

3.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

Authors:  F A Houssiau; J P Devogelaer; J Van Damme; C N de Deuxchaisnes; J Van Snick
Journal:  Arthritis Rheum       Date:  1988-06

4.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

5.  Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: comparison with conventional procedures and clinical applications.

Authors:  T Obayashi
Journal:  J Lab Clin Med       Date:  1984-09

6.  Establishment of a new perchloric acid treatment method to allow determination of the total endotoxin content in human plasma by the limulus test and clinical application.

Authors:  K Inada; S Endo; K Takahashi; M Suzuki; T Narita; T Yoshida; H Suda; T Komuro; M Yoshida
Journal:  Microbiol Immunol       Date:  1991       Impact factor: 1.955

7.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Authors:  S Okusawa; J A Gelfand; T Ikejima; R J Connolly; C A Dinarello
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

  7 in total
  1 in total

1.  Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis.

Authors:  Ryuji Koike; Masayoshi Harigai; Tatsuya Atsumi; Koichi Amano; Shinichi Kawai; Kazuyoshi Saito; Tomoyuki Saito; Masahiro Yamamura; Tsukasa Matsubara; Nobuyuki Miyasaka
Journal:  Mod Rheumatol       Date:  2009-07-10       Impact factor: 3.023

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.